Document Type

Article

Publication Date

2020

Keywords

Coronavirus, COVID-19, vaccines, intellectual property, preparedness, patents, public-private partnerships, CEPI, patent pledge

Abstract

The COVID-19 pandemic has shed renewed light on the importance of research and development (R&D) on biopharmaceutical products needed to prevent or lessen the burden posed by outbreaks of infectious diseases. Among these, the need for new vaccines has become of paramount importance. While a race to develop different types of vaccines unfolds at unusual speed, there are still significant shortcomings in the ecosystem that leads to the production and dissemination of vaccines targeting infectious diseases like COVID-19.

Share

COinS